Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
23.57
-0.20 (-0.84%)
At close: Sep 12, 2024, 4:00 PM
23.54
-0.03 (-0.13%)
Pre-market: Sep 13, 2024, 7:01 AM EDT
Nurix Therapeutics Employees
Nurix Therapeutics had 284 employees as of November 30, 2023. The number of employees decreased by 13 or -4.38% compared to the previous year.
Employees
284
Change (1Y)
-13
Growth (1Y)
-4.38%
Revenue / Employee
$219,377
Profits / Employee
-$580,993
Market Cap
1.52B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Nov 30, 2023 | 284 | -13 | -4.38% |
| Nov 30, 2022 | 297 | 55 | 22.73% |
| Nov 30, 2021 | 242 | 107 | 79.26% |
| Nov 30, 2020 | 135 | 42 | 45.16% |
| Nov 30, 2019 | 93 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| STAAR Surgical Company | 1,057 |
| Schrödinger | 867 |
| CareDx | 643 |
| Arcus Biosciences | 577 |
| BioCryst Pharmaceuticals | 536 |
| Harrow | 315 |
| Ardelyx | 267 |
| Syndax Pharmaceuticals | 184 |
NRIX News
- 7 days ago - Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit - GlobeNewsWire
- 8 days ago - Nurix Therapeutics: Promising Science, Major Collaborations, Undifferentiated Data - Seeking Alpha
- 15 days ago - Nurix Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 3 months ago - Nurix Therapeutics: Protein Deg Specialist's Latest Data Establishes Bull Case - Seeking Alpha
- 3 months ago - Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) - GlobeNewsWire
- 3 months ago - Nurix Therapeutics Appoints Paula G. O'Connor, M.D. - GlobeNewsWire
- 4 months ago - Nurix Therapeutics Announces Board Chair Transition - GlobeNewsWire